Ionis Pharmaceuticals (IONS) Net Equity Issued and Repurchased (2013 - 2024)

Ionis Pharmaceuticals (IONS) posted quarterly Net Equity Issued and Repurchased of $489.1 million for Q3 2024, down 21.74% quarter-over-quarter from $625.0 million in Q2 2018.

Ionis Pharmaceuticals (IONS) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends

Ionis Pharmaceuticals' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $489.1 million for Q3 2024.

  • In Q3 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $489.1 million; the TTM figure through Dec 2025 stood at $489.1 million (changed N/A YoY), while the FY2024 annual figure was $489.1 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q3 2024 stood at $489.1 million, down from $625.0 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $489.1 million in Q3 2024, with the low at $489.1 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Ionis Pharmaceuticals 9.48 Bn 7.43 Bn 265.21 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 489.10 Mn
Sep 30, 2024 489.10 Mn
Jun 30, 2018 625.00 Mn
Jun 30, 2018 625.00 Mn
Sep 30, 2017 97,000.00
Sep 30, 2017 97,000.00
Mar 31, 2017 71.64 Mn
Mar 31, 2017 71.64 Mn
Jun 30, 2013 173.30 Mn
Jun 30, 2013 173.30 Mn